AEMD (AETHLON MEDICAL INC) Stock Analysis - Financials

AETHLON MEDICAL INC (AEMD) is a publicly traded Healthcare sector company. As of May 21, 2026, AEMD trades at $2.08 with a market cap of $3.20M and a P/E ratio of -0.24. AEMD moved +0.49% today. Year to date, AEMD is -24.73%; over the trailing twelve months it is -93.69%. Its 52-week range spans $1.36 to $84.40. Rallies surfaces AEMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are AEMD's key financials?

AEMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AEMD recently traded at $2.08. Market cap is $3.20M. P/E ratio is -0.24. Revenue is $0.

AEMD Key Metrics

Key financial metrics for AEMD
MetricValue
Price$2.08
Market Cap$3.20M
P/E Ratio-0.24
EPS$-8.58
Dividend Yield0.00%
52-Week High$84.40
52-Week Low$1.36
Volume115.25K
Avg Volume0
Revenue (TTM)$0
Net Income$-13.39M
Gross Margin0.00%

AEMD Annual Financials

YearRevenueNet IncomeEPS
2025$0$-13.39M$-8.58
2024$0$-12.21M$-4.86
2023$574.25K$-12.03M$-0.59
2022$294.17K$-10.42M$0.00

Latest AEMD News

AEMD Analyst Consensus

AEMD analyst coverage data. Average price target: $0.00.

Common questions about AEMD

What are AEMD's key financials?
AEMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AEMD recently traded at $2.08. Market cap is $3.20M. P/E ratio is -0.24. Revenue is $0.
Is AEMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AEMD. It does not provide personalized investment advice.
AEMD

AEMD